Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Efficacy and Safety of a Proprietary Solution Containing Hypertonic Sodium Lactate (Totilac®) Infusion for Resuscitation of Patients With Hemorrhagic Shock Due to Multiple Injuries

NCT01433276 is registered in ClinicalTrials.gov with Innogene Kalbiotech Pte. Ltd as lead sponsor.

NCT NCT01433276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01433276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Efficacy and Safety of a Proprietary Solution Containing Hypertonic Sodium Lactate (Totilac®) Infusion for Resuscitation of Patients With Hemorrhagic Shock Due to Multiple Injuries
Lead sponsor
Innogene Kalbiotech Pte. Ltd
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2009
Completion date
January 31, 2011
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic shock